Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
Valerio Rosato, Mario Masarone, Marcello Dallio, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 18, pp. 3415-3415
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Current status and future trends of the global burden of MASLD
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 697-707
Closed Access | Times Cited: 183
Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway
Yaxing Kang, Yiran Song, Yuxin Luo, et al.
Free Radical Biology and Medicine (2022) Vol. 192, pp. 25-36
Closed Access | Times Cited: 69
Metabolic dysfunction-associated steatotic liver disease and its link to cancer
Markos Kalligeros, Linda Henry, Zobair M. Younossi
Metabolism (2024) Vol. 160, pp. 156004-156004
Closed Access | Times Cited: 18
Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus
Leonardo Spatola, Pietro Manuel Ferraro, Giovanni Gambaro, et al.
Metabolism (2018) Vol. 83, pp. 225-233
Closed Access | Times Cited: 100
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Marco Arrese, Juan Pablo Arab, Francisco Barrera, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 04, pp. 421-434
Open Access | Times Cited: 77
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications
Rossella Palma, Annamaria Pronio, Mario Romeo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3649-3649
Open Access | Times Cited: 43
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
M. V. Maevskaya, Yu. V. Kotovskaya, В. Т. Ивашкин, et al.
Terapevticheskii arkhiv (2022) Vol. 94, Iss. 2, pp. 216-253
Open Access | Times Cited: 40
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 10, pp. 2364-2405
Open Access | Times Cited: 38
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 23, Iss. 3, pp. 3696-3696
Open Access | Times Cited: 14
Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease
Jelena Stevanović, Jorge Beleza, Pedro Coxito, et al.
Molecular Metabolism (2019) Vol. 32, pp. 1-14
Open Access | Times Cited: 73
The non-invasive assessment of hepatic fibrosis
Gina Gheorghe, Simona Bungău, Gabriela Ceobanu, et al.
Journal of the Formosan Medical Association (2020) Vol. 120, Iss. 2, pp. 794-803
Open Access | Times Cited: 56
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes
Ferdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 8, pp. 2345-2353
Closed Access | Times Cited: 46
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 7, pp. 663-720
Open Access | Times Cited: 36
Recent update on application of dihydromyricetin in metabolic related diseases
Yirong Wang, Junmin Wang, Hongjiao Xiang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112771-112771
Open Access | Times Cited: 31
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease
Antonio Olveira, Salvador Augustín, Salvador Benlloch, et al.
Life (2023) Vol. 13, Iss. 2, pp. 419-419
Open Access | Times Cited: 17
Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment
Branka Filipović, Marija Marjanovic-Haljilji, Dragana Mijač, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9132-9148
Open Access | Times Cited: 16
Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study
Ae Hee Kim, Da‐Hye Son, Yong‐Jae Lee
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 6
Biomolecular Actions by Intestinal Endotoxemia in Metabolic Syndrome
Ioannis Alexandros Charitos, Maria Aliani, Pasquale Tondo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2841-2841
Open Access | Times Cited: 6
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition
Marcello Dallio, Moris Sangineto, Mario Romeo, et al.
Nutrition and Diabetes (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options
Daniela Maria Tănase, Evelina Maria Gosav, Ecaterina Neculae, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5927-5927
Open Access | Times Cited: 48
Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
Amedeo Lonardo
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 492-492
Open Access | Times Cited: 34
Exploration of Shared Gene Signatures and Molecular Mechanisms Between Periodontitis and Nonalcoholic Fatty Liver Disease
Wanqiu Xu, Zhengwei Zhang, Lihong Yao, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 24
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
Aamir Bashir, Ajay Duseja, Arka De, et al.
Liver Research (2022) Vol. 6, Iss. 2, pp. 72-83
Open Access | Times Cited: 23
Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives
Oxana M. Drapkina, Anastasia Yu. Elkina, А.Ф. Шептулина, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8445-8445
Open Access | Times Cited: 14
Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genes
Gamal A. Salem, Amany Abdel-Rahman Mohamed, Safaa I. Khater, et al.
Gene (2023) Vol. 883, pp. 147670-147670
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top